Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 23 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Procter & Gamble Hygiene and Health Care Ltd

About the Company - Procter & Gamble Hygiene and Health Care Ltd

Procter & Gamble Hygiene & Healthcare Ltd. is a Public Limited Listed company incorporated on 20/07/1964 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1964PLC012971 and registration number is 012971. Currently Company is involved in the business activities of Manufacture of `ayurvedic’ or `unani’ pharmaceutical preparation. Company’s Total Operating Revenue is Rs. 3900.92 Cr. and Equity Capital is Rs. 32.46 Cr. for the Year ended 30/06/2022.
INDUSTRYADDRESSCONTACT
Personal CareP & G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099investorpghh.im@pg.com
http://www.pg.com
Management
NamePosition Held
Mr. Chittranjan DuaChairman & Ind.Director
Mr. L V VaidyanathanManaging Director
Mr. Krishnamurthy IyerIndependent Director
Ms. Meena GaneshIndependent Director
Mr. Anil Kumar GuptaIndependent Director
Mr. Gurcharan DasIndependent Director
Mr. Karthik NatarajanNon Executive Director
Ms. Sonali DhawanNon Executive Director
Mr. Gagan SawhneyNon Executive Director
Mr. Pramod AgarwalNon Executive Director
Mr. Ghanashyam HegdeExecutive Director

Basic Stock Data of Procter & Gamble Hygiene and Health Care Ltd

Last Updated: June 22, 2024, 11:00 pm

Market Cap 52,656 Cr.
Current Price 16,221
High / Low19,250/13,943
Stock P/E70.7
Book Value 324
Dividend Yield0.65 %
ROCE101 %
ROE80.6 %
Face Value 10.0
PEG Ratio6.35

Competitors of Procter & Gamble Hygiene and Health Care Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Dabur India Ltd 1,07,872 Cr. 609634/48959.6 55.70.85 %22.3 %19.2 % 1.00
Hindustan Unilever Ltd 5,73,606 Cr. 2,4412,770/2,17055.8 2181.72 %27.2 %20.2 % 1.00
Zydus Wellness Ltd 11,771 Cr. 1,8501,973/1,42541.9 8420.27 %5.37 %5.36 % 10.0
JHS Svendgaard Laboratories Ltd 169 Cr. 21.539.5/15.5 21.70.00 %1.66 %2.37 % 10.0
Ador Multi Products Ltd 16.5 Cr. 35.352.6/29.1 23.60.00 %37.6 %28.3 % 10.0
Industry Average76,309.54 Cr1,553.2271.43187.850.59%33.34%19.52%5.91

Procter & Gamble Hygiene and Health Care Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales1,0187607871,0581,0939737761,0451,1378838531,1381,133
Expenses676631712757797808709831847734638853824
Operating Profit3421297530129616567214290149215285310
OPM %34%17%10%28%27%17%9%20%26%17%25%25%27%
Other Income915667667914101616
Interest2311371144323
Depreciation12111313131314141415151414
Profit before tax3381296729428815158206282146207284309
Tax %26%24%27%26%26%32%26%25%26%-13%27%26%26%
Net Profit251984921821210343154207165151211229
EPS in Rs77.2130.2915.0967.2565.3331.6813.1147.5763.9150.8446.5964.9170.52

Last Updated: June 5, 2024, 11:37 am

Procter & Gamble Hygiene and Health Care Ltd Quarterly Chart

Procter & Gamble Hygiene and Health Care Ltd Profit & Loss

Last Updated: June 1, 2024, 8:56 pm

MonthJun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023TTM
Sales1,2971,6772,0512,3342,2752,3202,4552,9473,0023,5743,9013,9184,011
Expenses1,0971,4201,6281,8381,6671,6461,8342,3292,3962,6883,0693,0483,072
Operating Profit201256423495608675622618606886832869940
OPM %15%15%21%21%27%29%25%21%20%25%21%22%23%
Other Income51617864856718454238234050
Interest00566105566111112
Depreciation28313553526052504848535859
Profit before tax223286460501636672582607594870790839918
Tax %19%29%34%31%34%36%36%31%27%25%27%19%
Net Profit181203302346422433375419433652576678734
EPS in Rs55.8562.6093.04106.63130.16133.31115.40129.12133.42200.79177.37208.91226.25
Dividend Payout %40%40%30%28%28%292%35%68%79%157%90%89%

Procter & Gamble Hygiene and Health Care Ltd Profit & Loss Yearly Chart

Procter & Gamble Hygiene and Health Care Ltd Growth

Compounded Sales Growth
10 Years:9%
5 Years:10%
3 Years:9%
TTM:7%
Compounded Profit Growth
10 Years:13%
5 Years:12%
3 Years:16%
TTM:31%
Stock Price CAGR
10 Years:15%
5 Years:10%
3 Years:8%
1 Year:21%
Return on Equity
10 Years:49%
5 Years:63%
3 Years:76%
Last Year:81%

Last Updated: June 17, 2024, 4:51 am

Procter & Gamble Hygiene and Health Care Ltd Balance Sheet

Last Updated: June 1, 2024, 8:56 pm

MonthJun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Dec 2023
Equity Capital32323232323232323232323232
Reserves6657739701,1961,6194947738771,1256827059141,020
Borrowings0000000003544
Other Liabilities4024445057195156346207086719159401,1871,170
Total Liabilities1,0991,2491,5081,9482,1661,1601,4251,6171,8281,6331,6832,1372,227
Fixed Assets198215240309317286250234206184164170160
CWIP29419839354121152238442320
Investments0000000000000
Other Assets8719931,1701,6001,8148341,1541,3681,6001,4111,4751,9452,047
Total Assets1,0991,2491,5081,9482,1661,1601,4251,6171,8281,6331,6832,1372,227

Procter & Gamble Hygiene and Health Care Ltd Reserves and Borrowings Chart

Procter & Gamble Hygiene and Health Care Ltd Cash Flow

MonthJun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023
Cash from Operating Activity 180104335426352445415413474863573826
Cash from Investing Activity -47-31-13528221149-1934757-27-10
Cash from Financing Activity -85-85-95-105-122-1,559-106-314-190-1,106-569-477
Net Cash Flow48-12105349452-964290134358-236-23339

Procter & Gamble Hygiene and Health Care Ltd Financial Efficiency Indicators

MonthJun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023
Debtor Days141815182421222220151820
Inventory Days646253475371486068785548
Days Payable178106103148134145156162175237183213
Cash Conversion Cycle-100-27-35-83-57-53-87-79-87-144-110-145
Working Capital Days53514348-15-23-12-21-38-34-53
ROCE %34%39%52%46%45%64%89%73%58%94%110%101%

Procter & Gamble Hygiene and Health Care Ltd Financial Efficiency Indicators Chart

Procter & Gamble Hygiene and Health Care Ltd Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%
FIIs2.53%2.57%2.63%2.25%2.03%1.68%1.12%1.05%1.13%1.30%1.48%1.57%
DIIs13.57%13.48%13.48%13.89%14.19%14.56%15.28%15.44%15.49%15.45%15.29%15.11%
Public13.27%13.31%13.26%13.22%13.14%13.12%12.96%12.87%12.73%12.61%12.60%12.67%
No. of Shareholders39,80641,12040,90840,81941,53343,44540,49539,96839,38837,06938,80739,999

Procter & Gamble Hygiene and Health Care Ltd Shareholding Pattern Chart

No. of Procter & Gamble Hygiene and Health Care Ltd Shareholders

Procter & Gamble Hygiene and Health Care Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Focused Equity Fund1,088,4706.111876.51300,0002024-06-22262.82%
SBI Equity Hybrid Fund430,0001.21741.32300,0002024-06-2243.33%
SBI Magnum Global Fund300,0008.15517.2300,0002024-06-220%
ICICI Prudential Bluechip Fund261,2641.01450.42300,0002024-06-22-12.91%
SBI Magnum Midcap Fund200,0002.39344.8300,0002024-06-22-33.33%
Aditya Birla Sun Life MNC Fund - Div72,4853.59124.96300,0002024-06-22-75.84%
Aditya Birla Sun Life MNC Fund - Gr72,4853.59124.96300,0002024-06-22-75.84%
SBI Conservative Hybrid Fund40,0000.7669.92300,0002024-06-22-86.67%
SBI Conservative Hybrid Fund - Div (Annual)40,0000.7669.92300,0002024-06-22-86.67%
SBI Conservative Hybrid Fund - Div (Monthly)40,0000.7669.92300,0002024-06-22-86.67%

Procter & Gamble Hygiene and Health Care Ltd ROCE Trend

Procter & Gamble Hygiene and Health Care Ltd EPS Trend

Procter & Gamble Hygiene and Health Care Ltd Key Financial Ratios

MonthJun 23Jun 22Jun 21Jun 20Jun 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)208.91177.37200.79133.42129.12
Diluted EPS (Rs.)208.91177.37200.79133.42129.12
Cash EPS (Rs.)226.89193.66215.48148.17144.46
Book Value[Excl.RevalReserv]/Share (Rs.)291.44227.22220.05356.70280.06
Book Value[Incl.RevalReserv]/Share (Rs.)291.44227.22220.05356.70280.06
Dividend / Share (Rs.)185.00160.00315.00105.0088.00
Revenue From Operations / Share (Rs.)1206.991201.761101.09924.83907.84
PBDIT / Share (Rs.)280.10263.16284.55199.57204.13
PBIT / Share (Rs.)262.12246.87269.87184.82188.79
PBT / Share (Rs.)258.62243.42267.99182.95187.10
Net Profit / Share (Rs.)208.91177.37200.80133.42129.12
PBDIT Margin (%)23.2021.8925.8421.5722.48
PBIT Margin (%)21.7120.5424.5019.9820.79
PBT Margin (%)21.4220.2524.3319.7820.60
Net Profit Margin (%)17.3014.7518.2314.4214.22
Return on Networth / Equity (%)71.6878.0691.2537.4046.10
Return on Capital Employeed (%)80.8597.31109.8748.6462.88
Return On Assets (%)31.7234.2439.9223.6825.68
Asset Turnover Ratio (%)2.052.352.071.741.93
Current Ratio (X)1.381.321.342.231.66
Quick Ratio (X)1.181.051.041.891.35
Inventory Turnover Ratio (X)3.745.224.975.225.83
Dividend Payout Ratio (NP) (%)0.0098.66169.3235.9761.95
Dividend Payout Ratio (CP) (%)0.0090.36157.7932.3955.37
Earning Retention Ratio (%)0.001.34-69.3264.0338.05
Cash Earning Retention Ratio (%)0.009.64-57.7967.6144.63
Interest Coverage Ratio (X)79.9076.34151.17106.72120.91
Interest Coverage Ratio (Post Tax) (X)60.5952.45107.6872.3577.48
Enterprise Value (Cr.)45454.0942869.0042606.6732060.9534210.09
EV / Net Operating Revenue (X)11.6010.9911.9210.6811.61
EV / EBITDA (X)49.9950.1946.1349.4951.63
MarketCap / Net Operating Revenue (X)11.8511.1512.1110.9811.79
Retention Ratios (%)0.001.33-69.3264.0238.04
Price / BV (X)49.0858.9960.5828.4738.23
Price / Net Operating Revenue (X)11.8511.1512.1110.9811.79
EarningsYield0.010.010.010.010.01

Procter & Gamble Hygiene and Health Care Ltd Profitability Ratios (%)

Procter & Gamble Hygiene and Health Care Ltd Liquidity Ratios

Procter & Gamble Hygiene and Health Care Ltd Liquidity Ratios (%)

Procter & Gamble Hygiene and Health Care Ltd Interest Coverage Ratios (%)

Procter & Gamble Hygiene and Health Care Ltd Valuation Ratios

Fair Value

Fair Value: 18,582.89

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 14.56% compared to the current price 16221

Intrinsic Value: 20,653.17

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 27.32% compared to the current price ₹16221

Last 5 Year EPS CAGR: 11.14%

*Investments are subject to market risks

Strength and Weakness of Procter & Gamble Hygiene and Health Care Ltd Stock

StrengthWeakness
  1. The stock has a high average ROCE of 67.08%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -3.08, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -83.92, which is a positive sign.
  4. The company has higher reserves (908.69 cr) compared to borrowings (1.23 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (2.31 cr) and profit (613.69 cr) over the years.

    Should I Buy Procter & Gamble Hygiene and Health Care Ltd Share Now?

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Procter & Gamble Hygiene and Health Care Ltd:
      1. Net Profit Margin: 17.30%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 80.85% (Industry Average ROCE: 47.41%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 71.68% (Industry Average ROE: 23.85%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 60.59
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.18
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. ✗ Stock P/E: 70.7 (Industry average Stock P/E: 44.36)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. ✗ Total Debt / Equity: N/A
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    FAQ

    What is the latest fair value of Procter & Gamble Hygiene and Health Care Ltd?

    The latest fair value of Procter & Gamble Hygiene and Health Care Ltd is ₹18582.89.

    What is the Market Cap of Procter & Gamble Hygiene and Health Care Ltd?

    The Market Cap of Procter & Gamble Hygiene and Health Care Ltd is 52,656 Cr..

    What is the current Stock Price of Procter & Gamble Hygiene and Health Care Ltd as on 23 June 2024?

    The current stock price of Procter & Gamble Hygiene and Health Care Ltd as on 23 June 2024 is ₹16,221.

    What is the High / Low of Procter & Gamble Hygiene and Health Care Ltd stocks in FY 2024?

    In FY 2024, the High / Low of Procter & Gamble Hygiene and Health Care Ltd stocks is 19,250/13,943.

    What is the Stock P/E of Procter & Gamble Hygiene and Health Care Ltd?

    The Stock P/E of Procter & Gamble Hygiene and Health Care Ltd is 70.7.

    What is the Book Value of Procter & Gamble Hygiene and Health Care Ltd?

    The Book Value of Procter & Gamble Hygiene and Health Care Ltd is 324.

    What is the Dividend Yield of Procter & Gamble Hygiene and Health Care Ltd?

    The Dividend Yield of Procter & Gamble Hygiene and Health Care Ltd is 0.65 %.

    What is the ROCE of Procter & Gamble Hygiene and Health Care Ltd?

    The ROCE of Procter & Gamble Hygiene and Health Care Ltd is 101 %.

    What is the ROE of Procter & Gamble Hygiene and Health Care Ltd?

    The ROE of Procter & Gamble Hygiene and Health Care Ltd is 80.6 %.

    What is the Face Value of Procter & Gamble Hygiene and Health Care Ltd?

    The Face Value of Procter & Gamble Hygiene and Health Care Ltd is 10.0.

    About the Author

    Author Avatar
    Getaka

    Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Procter & Gamble Hygiene and Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE